{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:04:02Z","timestamp":1770908642616,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.7759\/cureus.103468","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:02:35Z","timestamp":1770904955000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Non-selective Beta-Blockers on the Prevention of Decompensation in Compensated Cirrhosis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Ishtiaq","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":".","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajid","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1060073","article-title":"Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure","volume":"10","author":"Jagdish RK","year":"2023","unstructured":"Jagdish RK, Roy A, Kumar K, et al.. Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure. Front Med (Lausanne). 2023, 10:1060073. 10.3389\/fmed.2023.1060073","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100316","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri Y","year":"2021","unstructured":"Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep. 2021, 3:100316. 10.1016\/j.jhepr.2021.100316","journal-title":"JHEP Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v13.i4.179","article-title":"Compensated liver cirrhosis: natural course and disease-modifying strategies","volume":"13","author":"Kumar R","year":"2023","unstructured":"Kumar R, Kumar S, Prakash SS. Compensated liver cirrhosis: natural course and disease-modifying strategies. World J Methodol. 2023, 13:179-93. 10.5662\/wjm.v13.i4.179","journal-title":"World J Methodol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.12.001","article-title":"Beta-blockers in cirrhosis: evidence-based indications\u00a0and\u00a0limitations","volume":"2","author":"Rodrigues SG","year":"2020","unstructured":"Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications\u00a0and\u00a0limitations. JHEP Rep. 2020, 2:100063. 10.1016\/j.jhepr.2019.12.001","journal-title":"JHEP Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15559","article-title":"Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension","volume":"43","author":"Turco L","year":"2023","unstructured":"Turco L, Reiberger T, Vitale G, La Mura V. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension. Liver Int. 2023, 43:1183-94. 10.1111\/liv.15559","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1182","article-title":"Nonselective beta-blockers in portal hypertension: why, when, and how?","volume":"19","author":"Rabiee A","year":"2022","unstructured":"Rabiee A, Garcia-Tsao G, Tapper EB. Nonselective beta-blockers in portal hypertension: why, when, and how?. Clin Liver Dis (Hoboken). 2022, 19:118-23. 10.1002\/cld.1182","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.08.012","article-title":"Beta-blockers lower first decompensation in patients with cirrhosis and enduring portal hypertension after etiological treatment","volume":"23","author":"Turco L","year":"2025","unstructured":"Turco L, Taru MG, Vitale G, et al.. Beta-blockers lower first decompensation in patients with cirrhosis and enduring portal hypertension after etiological treatment. Clin Gastroenterol Hepatol. 2025, 23:987-996.e8. 10.1016\/j.cgh.2024.08.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","unstructured":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018, 69.406-60. 10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: using evidence-based practice in health education","volume":"21","author":"Brown D","year":"2020","unstructured":"Brown D. A review of the PubMed PICO tool: using evidence-based practice in health education. Health Promot Pract. 2020, 21:496-8. 10.1177\/1524839919893361","journal-title":"Health Promot Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"Beta-blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva C","year":"2019","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, et al.. Beta-blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019, 393:1597-608. 10.1016\/S0140-6736(18)31875-0","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann RJ","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, et al.. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005, 353:2254-61. 10.1056\/NEJMoa044456","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis","volume":"127","author":"Merkel C","year":"2004","unstructured":"Merkel C, Marin R, Angeli P, et al.. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 2004, 127:476-84. 10.1053\/j.gastro.2004.05.004","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9353-8","article-title":"Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial","volume":"7","author":"Sarin SK","year":"2013","unstructured":"Sarin SK, Mishra SR, Sharma P, Sharma BC, Kumar A. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial. Hepatol Int. 2013, 7:248-56. 10.1007\/s12072-012-9353-8","journal-title":"Hepatol Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311735","article-title":"Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial","volume":"66","author":"Bhardwaj A","year":"2017","unstructured":"Bhardwaj A, Kedarisetty CK, Vashishtha C, et al.. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut. 2017, 66:1838-43. 10.1136\/gutjnl-2016-311735","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension","volume":"11","author":"Cal\u00e9s P","year":"1999","unstructured":"Cal\u00e9s P, Oberti F, Payen JL, et al.. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol. 1999, 11:741-5. 10.1097\/00042737-199907000-00011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva C","year":"2016","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, et al.. Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016, 63:197-206. 10.1002\/hep.28264","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58296","article-title":"Safety of nonselective beta-blockers in decompensated liver cirrhosis and their role in inducing hepatorenal syndrome","volume":"16","author":"Qaqish F","year":"2024","unstructured":"Qaqish F, Dimachkie R, Sasso R, et al.. Safety of nonselective beta-blockers in decompensated liver cirrhosis and their role in inducing hepatorenal syndrome. Cureus. 2024, 16:e58296. 10.7759\/cureus.58296","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i32.11463","article-title":"Nonselective \u03b2-blockers may induce development of portal vein thrombosis in cirrhosis","volume":"20","author":"Qi XS","year":"2014","unstructured":"Qi XS, Bai M, Fan DM. Nonselective \u03b2-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol. 2014, 20:11463-6. 10.3748\/wjg.v20.i32.11463","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011510.pub2","article-title":"Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices","volume":"10","author":"Zacharias AP","year":"2018","unstructured":"Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018, 10:CD011510. 10.1002\/14651858.CD011510.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000321","article-title":"Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review","volume":"8","author":"Alsaeid M","year":"2024","unstructured":"Alsaeid M, Sung S, Bai W, et al.. Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review. Hepatol Commun. 2024, 8:10.1097\/HC9.0000000000000321","journal-title":"Hepatol Commun"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43253","article-title":"The efficacy of carvedilol in comparison to propranolol in reducing the hepatic venous pressure gradient and decreasing the risk of variceal bleeding in adult cirrhotic patients: a systematic review","volume":"15","author":"Dardari L","year":"2023","unstructured":"Dardari L, Taha M, Dahat P, et al.. The efficacy of carvedilol in comparison to propranolol in reducing the hepatic venous pressure gradient and decreasing the risk of variceal bleeding in adult cirrhotic patients: a systematic review. Cureus. 2023, 15:e43253. 10.7759\/cureus.43253","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i9.109691","article-title":"Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases","volume":"17","author":"Masood M","year":"2025","unstructured":"Masood M, Thandassery RB. Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases. World J Hepatol. 2025, 17:109691. 10.4254\/wjh.v17.i9.109691","journal-title":"World J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56010014","article-title":"The role of nonselective beta-blockers in compensated cirrhotic patients without major complications","volume":"56","author":"Yeh WS","year":"2019","unstructured":"Yeh WS, Yang SC, Liang CM, et al.. The role of nonselective beta-blockers in compensated cirrhotic patients without major complications. Medicina (Kaunas). 2019, 56:10.3390\/medicina56010014","journal-title":"Medicina (Kaunas)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-018-0420-z","article-title":"Small esophageal varices in patients with cirrhosis\u2014should we treat them?","volume":"17","author":"Reiberger T","year":"2018","unstructured":"Reiberger T, Bucsics T, Paternostro R, Pfisterer N, Riedl F, Mandorfer M. Small esophageal varices in patients with cirrhosis\u2014should we treat them?. Curr Hepatol Rep. 2018, 17:301-15. 10.1007\/s11901-018-0420-z","journal-title":"Curr Hepatol Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17380","article-title":"Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis","volume":"57","author":"Gillespie SL","year":"2023","unstructured":"Gillespie SL, Hanrahan TP, Rockey DC, Majumdar A, Hayes PC. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023, 57:454-63. 10.1111\/apt.17380","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454895-effect-of-non-selective-beta-blockers-on-the-prevention-of-decompensation-in-compensated-cirrhosis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:02:36Z","timestamp":1770904956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454895-effect-of-non-selective-beta-blockers-on-the-prevention-of-decompensation-in-compensated-cirrhosis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.103468","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}